Month: August 2021

VANCOUVER, British Columbia, Aug. 26, 2021 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies today announced the financial results for its fiscal second quarter ending June 30, 2021, and provided a corporate update. Fiscal Second Quarter Highlights and Recent DevelopmentsRakovina Therapeutics researchers are conducting in vitro analyses of kt-2000, kt-3000, and kt-4000 series compounds in high-throughput cellular and biochemical assays, benchmarked against FDA-approved cancer therapies. We have also established a cancer cell line repository representing a range of DNA-repair proficient and deficient cancers and commenced testing with all compound series. We have established a recombinant protein production...

– Company continues to increase R&D activities to advance clinical and preclinical programs – – Second quarter sales of $4,409,000 compared to $4,666,000 for second quarter 2020 – – Cash generated from operations of $2,128,000 in Q2 2021 compared to $2,195,000 in Q2 2020 – – Maintained production operations during COVID-19 pandemic, providing customers with essential products while ensuring the health and safety of our employees – EDMONTON, Alberta, Aug. 26, 2021 (GLOBE NEWSWIRE) — Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced financial results and operational highlights for the second quarter and six months ended June 30, 2021. “Progress continues...

SP Group generated revenue of DKK 1,238.5 million in the H1 2021 reporting period, an 11.1% improvement from DKK 1,114.4 million in H1 2020. EBITDA was up by 18.2% to DKK 210.4 million from DKK 178.0 million last year, and profit before tax was up 28.0% to DKK 129.5 million. Further upgrade of FY 2021 guidance following upgrade provided in Announcement no. 28/2021. SP Group now expects FY 2021 revenue to grow by 8% to 14% (previously 4% to 12%) for an EBITDA margin of 16.0% to 18.0% (unchanged) and an EBT margin of 9% to 12% (unchanged). AttachmentMeddelelse nr. 53 – Q2 – ENG – 26 08 21

Revenue Increases 66% Versus Q2 2020 HERZLIYA, Israel, Aug. 26, 2021 (GLOBE NEWSWIRE) — Safe-T® Group Ltd. (Nasdaq, TASE: SFET), a global provider of cyber-security and privacy solutions to consumers and enterprises, today announced record financial results for the three and six-month periods ended June 30, 2021.Revenues for the three-month period ended June 30, 2021, reached a record high, and totaled $1,784,000, an increase of 66% compared to $1,077,000 in the three-month period ended June 30, 2020. Revenues for the six–month period ended June 30, 2021,amounted to $3,131,000 (first six months of 2020: $2,165,000). The Company’s cash and cash equivalents and short-term investments balances at the end of the quarter were $19,304,000.Shachar Daniel, Chief Executive Officer of Safe-T Group, said, “The second quarter of...

Please find enclosed the presentation of Frontline Ltd.’s second quarter 2021 results to be held on the webcast / conference call 26 August, 2021 at 15:00 CET. This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.  AttachmentPresentation Q2 2021